Skip to main content

Patent Expiry

LXRX: INPEFA: recorded patent 8217156 expiry

October 7, 2030 · SOTAGLIFLOZIN. BioSniper AI can trace the company-impact path without requiring you to write the research question.

Event date
October 7, 2030
Company
LEXICON PHARMACEUTICALS, INC. (LXRX)
Drug
SOTAGLIFLOZIN
BioSniper AIPage evidence connected

Prepared research question

What could this event change, and which evidence should be watched next?

Run cited research

Traceable citations · Unknowns marked

Patent Expiry

INPEFA: recorded patent 8217156 expiry

Orange Book application NDA216203, product 001, listed patent 8217156 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source